3DM buys out Mach7 $60M deal signed, page-48

Agreed, fundamentals look solid, strategy is sound with direct dove-tailing now into Mach7's existing international markets and revenues.

Shouldn't stress about recent volatility, today's end-of-day drop from the daily high of 8.5c to 7.9c was driven by less than $29K worth of loose change in small sells, ie- low volumes. We may see some more stale shares and short term traders being cleaned out from the cupboard into early next week as we settle into this ride with the more serious longer term investors. Fin Review articles tends to bring the opportunistic out from the wood works, have to expect some chaff with the wheat.

Now looking forward to the CR and some more good news between now and Christmas from both sides of the business. This is the future of medicine people.



- My personal humble opinion only.